RGDS is a classic adhesion motif interacting with integrin receptors and influencing cell-matrix communication. The short sequence promotes studies of β-turn formation, surface binding, and ligand-receptor docking. Researchers use it to probe extracellular-matrix interactions and receptor specificity. Its simplicity supports widespread biochemical and structural analyses.
CAT No: R1883
CAS No:91037-65-9
Synonyms/Alias:Arg-gly-asp-ser;91037-65-9;Rgds peptide;Fibronectin tetrapeptide;Arginyl-glycyl-aspartyl-serine;RGDS;UNII-AC6UDA2MFC;L-Arginylglycyl-L-alpha-aspartyl-L-serine;AC6UDA2MFC;MFCD00076452;CHEMBL265628;(3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid;L-Serine, N-(N-(N-L-arginylglycyl)-L-alpha-aspartyl)-;RGDS peptide; Fibronectin tetrapeptide;Arg-Gly-Asp-Ser?;Fibronectin Inhibitor;Arg-Gly-Asp-Ser peptide;H-Arg-Gly-Asp-Ser-OH;L-Serine, L-arginylglycyl-L-alpha-aspartyl-;SCHEMBL7394659;DTXSID50920002;Fibronectin Inhibitor Tetrapeptide;CHEBI:232857;NNRFRJQMBSBXGO-CIUDSAMLSA-N;BDBM50241180;DU-728;RGDS peptide;Fibronectin tetrapeptide;AKOS024457642;Arg-Gly-Asp-Ser, >=95% (HPLC);CS-3266;FR73590;NCGC00167153-01;(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid;AS-56630;DA-61200;HY-12290;C77102;BRD-K08859203-001-01-9;L-SERINE, L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-;Q27273860;(3S)-3-{2-[(2S)-2-AMINO-5-CARBAMIMIDAMIDOPENTANAMIDO]ACETAMIDO}-3-{[(1S)-1-CARBOXY-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID;(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-16-hydroxy-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane-15-carboxylic acid;(S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((R)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;(S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butylcarboxamidomethylcarboxamido]-2-carboxy-(1S)-ethylcarboxamido]-3-hydroxy-(2S)-propanoic acid;2-{1-[1-amino-4-amino(imino)methylaminobutylcarboxamidomethylcarboxamido]-2-carboxyethylcarboxamido}-3-hydroxypropanoic acid;3-({2-[(2-Amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxyethylidene}amino)-4-[(1-carboxy-2-hydroxyethyl)imino]-4-hydroxybutanoic acid;3-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid (RGDS);
Chemical Name:(3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More